- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0127077

Bioliz Pharmaceuticals Private Limited
About Bioliz Pharmaceuticals Private Limited
Data last updated:
Bioliz Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 30 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2020PTC349167.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gudiya Devi Mukesh Kumar Pandey and Mukesh Kumar Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 221 Floor – 2 A Wing Mms Premises Wadala Truck Terminal Road Wadala, Mumbai, Maharashtra, India – 400037.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.5 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹63,884 (net margin 1.3%) and EBITDA of ₹1.07 Lakh (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years.
Bioliz Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0127077).
Company details
Recognitions & Rankings of Bioliz Pharmaceuticals
Contact details
Bioliz Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressA – 221 Floor – 2 A Wing Mms Premises Wadala Truck Terminal Road Wadala, Mumbai, Maharashtra, India – 400037
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bioliz Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Bioliz Pharmaceuticals Private Limited, buy the company report.
Financials of Bioliz Pharmaceuticals Private Limited
FY 2025 filings availableBioliz Pharmaceuticals Private Limited reported revenue of ₹48.5 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over three years, including 19% growth in the latest year. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63,884 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioliz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bioliz Pharmaceuticals Private Limited
Bioliz Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gudiya Devi Mukesh Kumar Pandey | Director | 30 Oct 2020 | 6 Years 0 Months | Current |
| Mukesh Kumar Pandey | Director | 30 Oct 2020 | 6 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Bioliz Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioliz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bioliz Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bioliz Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Gudiya Devi Mukesh Kumar Pandey was appointed as Director on 30 Oct 2020.
Frequently asked questions
Bioliz Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 30 October 2020 (6+ years old) and is registered under CIN U24230MH2020PTC349167.
Bioliz Pharmaceuticals has 2 current directors:
- Gudiya Devi Mukesh Kumar Pandey - Director
- Mukesh Kumar Pandey - Director
The latest financial statements of Bioliz Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Bioliz Pharmaceuticals is U24230MH2020PTC349167. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioliz Pharmaceuticals was incorporated on 30 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Gudiya Devi Mukesh Kumar Pandey was appointed as Director on 30 Oct 2020. Mukesh Kumar Pandey was appointed as Director on 30 Oct 2020.
Yes, Bioliz Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0127077).
The registered office of Bioliz Pharmaceuticals is at A – 221 Floor – 2 A Wing Mms Premises Wadala Truck Terminal Road Wadala, Mumbai, Maharashtra, India – 400037.
Bioliz Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Bioliz Pharmaceuticals can be reached at its registered office: A – 221 Floor – 2 A Wing Mms Premises Wadala Truck Terminal Road Wadala, Mumbai, Maharashtra, India – 400037.

